These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6545278)

  • 1. Biomonitoring of chemicals and their metabolites.
    van Sittert NJ
    IARC Sci Publ; 1984; (59):153-72. PubMed ID: 6545278
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenesis, carcinogenesis and alkylating properties of nitrosamines and related compounds.
    Lijinsky W
    Prog Clin Biol Res; 1986; 209B():141-8. PubMed ID: 3749074
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacterial urinary assay in monitoring exposure to mutagens and carcinogens.
    Vainio H; Sorsa M; Falck K
    IARC Sci Publ; 1984; (59):247-58. PubMed ID: 6400094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of various methodologies with respect to specificity and sensitivity in biomonitoring occupational exposure to mutagens and carcinogens.
    Lohman PH; Jansen JD; Baan RA
    IARC Sci Publ; 1984; (59):259-77. PubMed ID: 6545282
    [No Abstract]   [Full Text] [Related]  

  • 5. Conjugation reactions in foreign-compound metabolism: definition, consequences, and species variations.
    Caldwell J
    Drug Metab Rev; 1982; 13(5):745-77. PubMed ID: 6754307
    [No Abstract]   [Full Text] [Related]  

  • 6. Basic concepts of monitoring human exposure.
    Lauwerys R
    IARC Sci Publ; 1984; (59):31-6. PubMed ID: 6545283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical approaches to assessing the action of carcinogens on the human body].
    Rubenchik BL
    Vopr Onkol; 1983; 29(10):73-9. PubMed ID: 6356584
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular dosimetry techniques in human risk assessment: an industrial perspective.
    Wright AS
    Dev Toxicol Environ Sci; 1983; 11():311-8. PubMed ID: 6329628
    [No Abstract]   [Full Text] [Related]  

  • 10. Human metabolic variability in xenobiotic biotransformation: implications for genotoxicity.
    Pelkonen O; Sotaniemi EA; Kärki NT
    Prog Clin Biol Res; 1982; 109():61-73. PubMed ID: 7167561
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of chemicals to proximal carcinogens.
    Sugimura T; Wakabayashi K; Yamada M; Nagao M; Fujino T
    Dev Toxicol Environ Sci; 1980; 8():205-17. PubMed ID: 6796373
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomonitoring of human exposure to alkylating agents by measurement of adducts to haemoglobin or DNA.
    Farmer PB; Bailey E; Green JA; Leung CS; Manson MM
    IARC Sci Publ; 1991; (105):71-7. PubMed ID: 1855925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of mammalian metabolism into mutagenicity testing.
    Malling HV
    Mutat Res; 2004 May; 566(3):183-9. PubMed ID: 15082236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive metabolites from N-nitrosamines.
    Archer MC; Milligan JR; Skotnicki S; Lu SJ
    Adv Exp Med Biol; 1991; 283():521-4. PubMed ID: 2069023
    [No Abstract]   [Full Text] [Related]  

  • 15. Absorption and disposition of MeIQx in man: lessons for human dosimetry.
    Boobis AR; Gooderham NJ; Murray BP; Murray S; Lynch A; Sesardic D; Davies DS
    Prog Clin Biol Res; 1991; 372():89-98. PubMed ID: 1956951
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of modifying structure on electrophilic reactions with biological nucleophiles.
    Coles B
    Drug Metab Rev; 1984-1985; 15(7):1307-34. PubMed ID: 6398776
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactive metabolites of 1,3-butadiene: DNA and hemoglobin adduct formation and potential roles in carcinogenicity.
    Elfarra AA; Moll TS; Krause RJ; Kemper RA; Selzer RR
    Adv Exp Med Biol; 2001; 500():93-103. PubMed ID: 11765021
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biotransformation in occupational medicine: the role of hepatic cytochrome P-450 in the mechanism of action and the biological monitoring of occupational toxic compounds].
    Manno M; Saia B
    Med Lav; 1994; 85(1):11-21. PubMed ID: 8035741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfotransferase-mediated activation of 4-hydroxy- and 3,4-dihydroxy-3,4-dihydrocyclopenta[c,d]pyrene, major metabolites of cyclopenta[c,d]pyrene.
    Surh YJ; Kwon H; Tannenbaum SR
    Cancer Res; 1993 Mar; 53(5):1017-22. PubMed ID: 8439948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tobacco smoking related DNA and protein adducts and risk of degenerative diseases].
    Baer-Dubowska W
    Przegl Lek; 2006; 63(10):932-5. PubMed ID: 17288187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.